Effects of tadalafil administration on plasma markers of exercise-induced muscle damage, IL6 and antioxidant status capacity

European Journal of Applied Physiology

Volumn 115, Issue 3, 2015, Pages 531-539

  Ceci, Roberta ^a   Duranti, Guglielmo ^a   Sgrò, Paolo ^a   Sansone, Massimiliano ^a   Guidetti, Laura ^a   Baldari, Carlo ^a   Sabatini, Stefania ^a   Di Luigi, Luigi ^a  

^a UNIVERSITY OF ROME FORO ITALICO   (Italy)

Author keywords

Exhaustive exercise test; Muscle damage; Oxidative stress; Tadalafil; Type 5 phosphodiesterase inhibitors

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CARBOLINE DERIVATIVE; CREATINE KINASE; GLUTATHIONE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MALONALDEHYDE; PHOSPHODIESTERASE V INHIBITOR; TADALAFIL;

ADULT; BLOOD; CONTROLLED STUDY; DRUG EFFECTS; EXERCISE; FEMALE; HUMAN; MALE; METABOLISM; MYALGIA; OXIDATIVE STRESS; PHYSIOLOGY; PROTEIN CARBONYLATION; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; CARBOLINES; CREATINE KINASE; EXERCISE; FEMALE; GLUTATHIONE; HUMANS; INTERLEUKIN-6; L-LACTATE DEHYDROGENASE; MALE; MALONDIALDEHYDE; MUSCLE, SKELETAL; MYALGIA; OXIDATIVE STRESS; PHOSPHODIESTERASE 5 INHIBITORS; PROTEIN CARBONYLATION;

EID: 84925539315     PISSN: 14396319     EISSN: 14396327     Source Type: Journal    
DOI: 10.1007/s00421-014-3040-5     Document Type: Article

References (47)

1. Anderson ME (1985) Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 113:548–555
2. Arif SA, Poon H (2011) Tadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension. Clin Ther 33(8):993–1004
3. Baghdadi HH, Allam A, Sheweita SA (2013) Erectile dysfunction medication induced-changes in plasma levels of homocysteine and antioxidant enzyme activities as risk factors for cardiovascular disease. J Taibah Univ Med Sci 8(3):151–156
4. Bentley DJ, Dank S, Coupland R, Midgley A, Spence I (2012) Acute antioxidant supplementation improves endurance performance in trained athletes. Res Sports Med 20(1):1–12
5. Ceci R, Beltran Valls MR, Duranti G, Dimauro I, Quaranta F, Pittaluga M, Sabatini S, Caserotti P, Parisi P, Parisi A, Caporossi D (2014) Oxidative stress responses to a graded maximal exercise test in older adults following explosive-type resistance training. Redox Biol 2:65–72
6. Chen Y, Li XX, Lin HC, Qiu XF, Gao J, Dai YT, Wang R (2012) The effects of long-term administration of tadalafil on STZ-induced diabetic rats with erectile dysfunction via a local antioxidative mechanism. Asian J Androl 14(4):616–620
7. Corbin JD, Francis SH (2002) Pharmacology of phosphodiesterase-5 inhibitors. Int J Clin Pract 56(6):453–459
8. Crescioli C, Sturli N, Sottili M, Bonini P, Lenzi A, Di Luigi L (2013) Insulin-like effect of the phosphodiesterase type 5 inhibitor tadalafil onto male human skeletal muscle cells. J Endocrinol Invest 36(11):1020–1026
9. Davies KJ, Quintanilha AT, Brooks GA, Packer L (1982) Free radicals and tissue damage produced by exercise. Biochem Biophys Res Commun 107(4):1198–1205
10. 2max, aerobic, and anaerobic thresholds in normoxia. Int J Sports Med 29(2):110–115
11. Di Luigi L, Sgrò P, Baldari C, Gallotta MC, Emerenziani GP, Crescioli C, Bianchini S, Romanelli F, Lenzi A, Guidetti L (2012) The phosphodiesterases type 5 inhibitor tadalafil reduces the activation of the hypothalamus-pituitary-adrenal axis in men during cycle ergometric exercise. Am J Physiol Endocrinol Metab 302(8):E972–E978
12. Draeger CL et al (2014) Controversies of antioxidant vitamins supplementation in exercise: ergogenic or ergolytic effects in humans? J Int Soc Sports Nutr 11(1):4
13. Falone S, Mirabilio A, Pennelli A, Cacchio M, Di Baldassarre A, Gallina S, Passerini A, Amicarelli F (2010) Differential impact of acute bout of exercise on redox- and oxidative damage-related profiles between untrained subjects and amateur runners. Physiol Res 59(6):953–961
14. Fan YF, Zhang R, Jiang X, Wen L, Wu DC, Liu D, Yuan P, Wang YL, Jing ZC (2013) The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension. Cardiovasc Res 99(3):395–403
15. 2 generation by rat heart mitochondria. Mol Cell Biochem 309(1–2):77–85
16. Fisher-Wellman K, Bloomer RJ (2009) Acute exercise and oxidative stress: a 30 year history. Dyn Med. doi:10.1186/1476-5918-8-1
17. Francis SH, Busch JL, Corbin JD, Sibley D (2010) cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev 62(3):525–563
18. Freeman B (1994) Free radical chemistry of nitric oxide. Looking at the dark side. Chest 105:79S–84S
19. Gasperi V, Ceci R, Tantimonaco M, Talamonti E, Battista N, Parisi A, Florio R, Sabatini S, Rossi A, Maccarrone M (2014) The fatty acid amide hydrolase in lymphocytes from sedentary and active subjects. Med Sci Sports Exerc. 46(1):24–32
20. Ji LL, Gomez-Cabrera MC, Vina J (2006) Exercise and hormesis: activation of cellular antioxidant signaling pathway. Ann N Y Acad Sci 1067:425–435
21. Koka S, Das A, Salloum FN, Kukreja RC (2013) Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice. Free Radic Biol Med 60:80–88
22. Korkmaz S, Radovits T, Barnucz E, Neugebauer P, Arif R, Hirschberg K, Loganathan S, Seidel B, Karck M, Szabó G (2009) Dose-dependent effects of a selective phosphodiesterase-5-inhibitor on endothelial dysfunction induced by peroxynitrite in rat aorta. Eur J Pharmacol 615(1–3):155–162
23. Lewis GD, Lachmann J, Camuso J, Lepore JJ, Shin J, Martinovic ME, Systrom DM, Bloch KD, Semigran MJ (2007) Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation 115(1):59–66
24. Lu Z, Xu X, Hu X, Lee S, Traverse JH, Zhu G, Fassett J, Tao Y, Zhang P, dos Remedios C, Pritzker M, Hall JL, Garry DJ, Chen Y (2010) Oxidative stress regulates left ventricular PDE5 expression in the failing heart. Circulation 121(13):1474–1483
25. Milara J, Juan G, Ortiz JL, Guijarro R, Losada M, Serrano A, Morcillo EJ, Cortijo J (2010) Cigarette smoke-induced pulmonary endothelial dysfunction is partially suppressed by sildenafil. Eur J Pharm Sci 39(5):363–372
26. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner AA (1993) A novel method for measuring antioxidant capacity and its application to monitor the antioxidant status in premature neonates. Clin Sci 84:407–412
27. Morano S, Mandosi E, Fallarino M, Gatti A, Tiberti C, Sensi M, Gandini L, Buchetti B, Lenti L, Jannini EA, Lenzi A (2007) Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study. Eur Urol 52(6):1768–1774
28. Myburgh KH (2014) Polyphenol supplementation: benefits for exercise performance or oxidative stress? Sports Med 44(1):57–70
29. Ndahala AR, Moyo M, Van Staden J (2010) Natural antioxidants: fascinating or mythical biomolecules? Molecules 15:6905–6930
30. Ozdegirmenci O, Kucukozkan T, Akdag E, Topal T, Haberal A, Kayir H, Oter S, Akyol M, Uzbay T (2011) Effects of sildenafil and tadalafil on ischemia/reperfusion injury in fetal rat brain. J Matern Fetal Neonatal Med 24(2):317–323
31. Pedersen BK, Febbraio MA (2008) Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 88(4):1379–1406
32. Perk H, Armagan A, Naziroğlu M, Soyupek S, Hoscan MB, Sütcü R, Ozorak A, Delibas N (2008) Sildenafil citrate as a phosphodiesterase inhibitor has an antioxidant effect in the blood of men. J Clin Pharm Ther 33(6):635–640
33. Pittaluga M, Parisi P, Sabatini S, Ceci R, Caporossi D, Valeria Catani M, Savini I, Avigliano L (2006) Cellular and biochemical parameters of exercise-induced oxidative stress: relationship with training levels. Free Radic Res. 40(6):607–614
34. Powers SK, Jackson MJ (2008) Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev 88(4):1243–1276
35. Powers SK, DeRuisseau KC, Quindry J, Hamilton KL (2004) Dietary antioxidants and exercise. J Sports Sci 22(1):81–94
36. Powers SK, Nelson WB, Hudson MB (2011) Exercise-induced oxidative stress in humans: cause and consequences. Free Radic Biol Med 51(5):942–950
37. Radak Z, Zhao Z, Koltai E, Ohno H, Atalay M (2013) Oxygen consumption and usage during physical exercise: the balance between oxidative stress and ROS-dependent adaptive signaling. Antioxid Redox Signal 18(10):1208–1246
38. Sabatini S, Sgrò P, Duranti G, Ceci R, Di Luigi L (2011) Tadalafil alters energy metabolism in C2C12 skeletal muscle cells. Acta Biochim Pol 58(2):237–241
39. Salloum FN, Chau VQ, Hoke NN, Abbate A, Varma A, Ockaili RA, Toldo S, Kukreja RC (2009) Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide. Circulation 120(11 Suppl):S31–S36
40. Savas M, Yeni E, Verit A, Gulum M, Aksoy N, Ciftci H, Celik H, Altunkol A, Once H (2010) Acute effect of phosphodiesterase type 5 inhibitor on serum oxidative status and prolidase activities in men with erectile dysfunction. Clinics 65(12):1311–1314
41. Serarslan Y, Yönden Z, Ozgiray E, Oktar S, Güven EO, Söğüt S, Yilmaz N, Yurtseven T (2010) Protective effects of tadalafil on experimental spinal cord injury in rats. J Clin Neurosci 17(3):349–352
42. Sousa M, Teixeira VH, Soares J (2014) Dietary strategies to recover from exercise-induced muscle damage. Int J Food Sci Nutr 65(2):151–163
43. Speranza L, Franceschelli S, Pesce M, Vinciguerra I, De Lutiis MA, Grilli A, Felaco M, Patruno A (2008) Phosphodiesterase type-5 inhibitor and oxidative stress. Int J Immunopathol Pharmacol 21:879–889
44. Stamler JS, Singel DJ, Loscalzo J (1992) Biochemistry of nitric oxide and its redox-activated forms. Science 258:1898–1902
45. Suhr F, Gehlert S, Grau M, Bloch W (2013) Skeletal muscle function during exercise-fine-tuning of diverse subsystems by nitric oxide. Int J Mol Sci. 14(4):7109–7139
46. Vachiery JL, Huez S, Gillies H, Layton G, Hayashi N, Gao X, Naeije R (2011) Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension. Br J Clin Pharmacol 71(2):289–292
47. Wright PJ (2006) Comparison of phosphodiesterase type 5 (PDE5) inhibitors. Int J Clin Pract 60(8):967–975